Newgenivf Group LTD 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
NASDAQ
NewGenIvf Group Limited has finalized its business combination with A SPAC I Acquisition Corp., and its shares and warrants are scheduled to commence trading on the Nasdaq Capital Market on April 4, 2024.